Results 21 to 30 of about 812 (121)
Revista Información Científica, 2023 Introducción: la hipertensión perioperatoria constituye una de las principales alteraciones detectadas durante la colecistectomía video endoscópica. Se presume del efecto protector que tiene el atenolol con su acción beta bloqueadora en reducir esta ...
Yulieth Reyes-Ochoa +4 more
doaj +1 more source
Jurnal Farmasi Sains dan Komunitas, 2017 Atenolol, a competitive beta (1)-selective adrenergic antagonists, has been widely used in hypertension therapy. Administration of conventional tablets of atenolol has limitation due to patient compliance in geriatric patients. Formulation of atenolol as
Karina Citra Rani +2 more
doaj +1 more source
Aesthetic Outcome of Propranolol vs Atenolol Treatment of Children with Infantile Haemangioma
Acta Dermato-Venereologica, 2022 Infantile haemangiomas are common benign tumours of infancy, which can be treated effectively with beta-blockers such as propranolol and atenolol. Different types of beta-blockers may result in different long-term aesthetic outcomes. This study evaluated
Mireille M. Hermans +13 more
doaj +1 more source
Melatonin Levels in 89 Individuals With Smith Magenis Syndrome
American Journal of Medical Genetics Part A, EarlyView.ABSTRACT In patients with Smith–Magenis syndrome (SMS), an inverted circadian rhythm of melatonin (MT) contributes to the sleep disturbance. Standard treatment of sleep disturbance with MT often leads to extremely high daytime MT levels, resulting in even more sleep disorders. We therefore retrospectively evaluated the MT data of 89 SMS patients.
Wiebe Braam, Ann C. M. Smith
wiley +1 more source
A molecular inclusion complex of atenolol with 2-hydroxypropyl-b-cyclodextrin; the production and characterization thereof [PDF]
Journal of the Serbian Chemical Society, 2007 The molecular inclusion complex of atenolol with 2-hydroxypropyl-b-cyclodextrin was synthesized using the coprecipitation method. The complex obtained was characterized by FT-IR, 1H‑NMR, 13C-NMR spectroscopy, as well as by DSC and X-ray diffraction ...
VESNA NIKOLIC +5 more
doaj
British Journal of Clinical Pharmacology, EarlyView.Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić +4 more
wiley +1 more source
International Journal of Electrochemical Science, 2010 A simple, rapid and sensitive electrochemical method for simultaneous determination of acetaminophen and atenolol was developed in Britton-Robinson buffer solution on a gold nanoparticles carbon paste electrode (GN-CPE).
Mohsen Behpour +2 more
doaj +1 more source
Pakistan Journal of Pharmaceutical Sciences, 2021 Blood pressure control in hypertensive patients with metabolic abnormalities is challenging because many antihypertensive drugs adversely affect metabolism.
Abdul Majid +5 more
doaj +1 more source
Metabolomic investigation of cisplatin‐induced acute kidney injury in paediatric cancer patients
British Journal of Clinical Pharmacology, EarlyView.Aim Cisplatin causes acute kidney injury (AKI) in approximately 46% of paediatric cancer patients who receive it. Serum creatinine (SCr) is a poor biomarker of cisplatin nephrotoxicity, because there is a delay between cisplatin infusion and SCr elevation.
Yong Jin Lim +37 more
wiley +1 more source
Hepatotoxicity of atenolol therapy - A report of 2 cases
Journal of Acute Disease, 2013 This case report highlights atenolol induced episodes of chronic and acute hepatotoxicities in 2 elderly hypertensive patients. The 1st patient manifested liver dysfunction after 8 months of 50 mg daily atenolol therapy and in the 2nd patient liver ...
Somnath Mondal +6 more
doaj +1 more source